Browsing Tag
LENSai
1 post
ImmunoPrecise (NASDAQ: IPA) validates AI-discovered universal dengue vaccine target with confirmed safety, immune activation, and structural stability
ImmunoPrecise (NASDAQ: IPA) validates AI-engineered dengue vaccine with confirmed immune activation, safety, and stability, marking a new era in AI-driven drug discovery.